Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Pharmaids Pharmaceuticals
Start SIPPharmaids Pharmaceuticals Investment Rating
-
Master Rating:
-
Pharmaids Pharms. has an operating revenue of Rs. 3.94 Cr. on a trailing 12-month basis. An annual revenue de-growth of -54% needs improvement, Pre-tax margin of 4% needs improvement, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 6 which is a POOR score indicating inconsistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 0 | 0 | 0 | 0 |
| Operating Expenses Qtr Cr | 1 | 1 | 0 | 0 |
| Operating Profit Qtr Cr | -1 | -1 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | -1 | -1 | 0 | 0 |
Pharmaids Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- 25.75
- 50 Day
- 22.1
- 100 Day
- 18.77
- 200 Day
- 16.44
- 20 Day
- 27.56
- 50 Day
- 20.39
- 100 Day
- 16.96
- 200 Day
- 14.69
Pharmaids Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 25 |
| Second Resistance | 25.85 |
| Third Resistance | 26.27 |
| RSI | 43.56 |
| MFI | 65.74 |
| MACD Single Line | 2.29 |
| MACD | 1.26 |
| Support | |
|---|---|
| First Resistance | 23.73 |
| Second Resistance | 23.31 |
| Third Resistance | 22.46 |
Pharmaids Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 26,292 | 2,629,200 | 100 |
| Week | 26,292 | 2,629,200 | 100 |
| 1 Month | |||
| 6 Month | 20,566 | 1,842,742 | 89.6 |
Pharmaids Pharmaceuticals Result Highlights
Pharmaids Pharmaceuticals Synopsis
BSE-Medical-Diversified
Pharmaids Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 3.94 Cr. and Equity Capital is Rs. 10.27 Cr. for the Year ended 31/03/2022. Pharmaids Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L52520TG1989PLC009679 and registration number is 009679.| Market Cap | 43 |
| Sales | 0 |
| Shares in Float | 1.10 |
| No of funds | |
| Yield |
| Book Value | 2.72 |
| U/D Vol ratio | 2.5 |
| LTDebt / Equity | |
| Alpha | 0.37 |
| Beta | 0.52 |
Pharmaids Pharmaceuticals
| Owner Name | Jan-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 16.45% | 16.54% | 21.08% | |
| Individual Investors | 69.87% | 69.78% | 74.07% | |
| Others | 13.68% | 13.68% | 4.85% |
Pharmaids Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mrs. S Padmaja Kalyani | Executive Director |
| Mr. S Vishwa Prasad | Executive Director |
| Mr. Sadhanala Venkata Rao | Non Exe.Non Ind.Director |
| Mr. Mopperthy Sudheer | Independent Director |
| Mr. Veerareddy Vallapureddy | Independent Director |
| Dr. Vyasmurti Madhavrao Shingatgeri | Independent Director |
Pharmaids Pharmaceuticals Forecast
Price Estimates
Pharmaids Pharmaceuticals FAQs
What is Share Price of Pharmaids Pharmaceuticals ?
Pharmaids Pharmaceuticals share price is ₹23 As on 25 March, 2023 | 14:00
What is the Market Cap of Pharmaids Pharmaceuticals ?
The Market Cap of Pharmaids Pharmaceuticals is ₹30.1 Cr As on 25 March, 2023 | 14:00
What is the P/E ratio of Pharmaids Pharmaceuticals ?
The P/E ratio of Pharmaids Pharmaceuticals is -21.7 As on 25 March, 2023 | 14:00
What is the PB ratio of Pharmaids Pharmaceuticals ?
The PB ratio of Pharmaids Pharmaceuticals is 3.5 As on 25 March, 2023 | 14:00